Indeed, promoting GHS-R1a signalling, using synthetic agonist compounds, or inhibiting ghrelin de-acylation enzymes may be a valuable tool in promoting hippocampal ghrelin–GHS-R1a signalling, offering novel therapies to ameliorate cognitive decline and mood-related disorders in humans. Here, GHSR is linked to Mental deterioration.